Trial NCT00381836

View at ClinicalTrials.gov 
Org. Study IDs: 2005-005658-37
Secondary IDs: Data Protection: 2005-41-6015 Ethical: 20060074 LM: 2612-3148

Last trial update was posted on 2015-12-04

MeSH Interventions

Darbepoetin alfa

MeSH Conditions

Anemia Prostatic Neoplasms

Other Conditions


Stopping Reasons

Terminated by sponsor due to general risk that aranesp caused tumor progression

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID